Tribute Pharmaceuticals Canada Inc. (TBUFF) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 15 transactions totaling $2.5M, demonstrating a bullish sentiment with $2.5M in net insider flow. The most recent transaction on Mar 4, 2013 involved a purchase of 625,000 shares valued at $0.
No significant insider buying has been recorded for TBUFF in the recent period.
No significant insider selling has been recorded for TBUFF in the recent period.
Based on recent SEC filings, insider sentiment for TBUFF is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Tribute Pharmaceuticals Canada Inc. (TBUFF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading TBUFF stock, having executed 15 transactions in the past 90 days. The most active insider is Robert Paul Harris (Executive), who has made 3 transactions totaling $866.0K.
Get notified when executives and directors at TBUFF file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 625,000 | $N/A | $0 | |
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 1,250,000 | $N/A | $0 | |
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 625,000 | $N/A | $0 | |
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 1,250,000 | $N/A | $0 | |
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 625,000 | $N/A | $0 | |
| Mar 4, 2013 | M. Gregory John | Executive | Purchase | 625,000 | $N/A | $0 | |
| Feb 27, 2013 | Management Inc. Elora Financial | Executive | Purchase | 62,500 | $0.40 | $25.0K | |
| Feb 27, 2013 | Tenney Arnold | Executive | Purchase | 250,000 | $0.40 | $100.0K | |
| Feb 27, 2013 | Martin Thrasher Francis | Executive | Purchase | 1,250,000 | $0.40 | $500.0K | Large |
| Feb 27, 2013 | Harold Goldman Steven | Executive | Purchase | 550,000 | $0.40 | $220.0K | |
| Feb 27, 2013 | Harold Goldman Steven | Executive | Purchase | 700,000 | $0.40 | $280.0K | |
| Feb 27, 2013 | Paul Harris Robert | Executive | Purchase | 625,000 | $0.40 | $250.0K | |
| Mar 22, 2012 | Management Inc. Elora Financial | Executive | Purchase | 900,000 | $0.56 | $504.0K | Large |
| Mar 22, 2012 | Paul Harris Robert | Executive | Purchase | 550,000 | $0.56 | $308.0K | |
| Mar 22, 2012 | Paul Harris Robert | Executive | Purchase | 550,000 | $0.56 | $308.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $2.5M | 100.0% |
Insiders at Tribute Pharmaceuticals Canada Inc. are accumulating shares at an accelerated pace. With 6 insiders making 15 transactions totaling $2.5M in purchases versus $0 in sales, the net buying activity of $2.5M signals strong executive confidence. Robert Paul Harris (Executive) leads the buying activity with $866.0K in transactions across all time.